Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia × In Situ Hybridization, Fluorescence × Clear all

Sponsor

Conditions

Waldenstrom Macroglobulinemia 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Congenital Abnormalities 4 Sezary Syndrome 3 Myeloproliferative Disorders 3 Mycosis Fungoides 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myeloid, Acute 3 Burkitt Lymphoma 3 Rectal Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Epoetin Alfa 7 Darbepoetin alfa 6 epoetin beta 4 Lenalidomide 4 Cyclophosphamide 4 ACE-011 4 fludarabine 3 Busulfan 3 thymoglobulin 2 telapristone acetate 2 luspatercept 2 fludarabine phosphate 2 Cyclosporine 2 Antilymphocyte Serum 2 AP 1903 reagent 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 vactosertib 1 ruxolitinib 1 roxadustat 1 obinutuzumab 1 ibrutinib 1 fosphenytoin 1 ferrous sulfate 1 ferric gluconate 1 ferric carboxymaltose 1 eltrombopag 1 angiotensin I (1-7) 1 Whole-Body Irradiation 1 Thiotepa 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡